Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent LeasesGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Biofrontera (BFRI) Short-term Investments: 2022-2024

Historic Short-term Investments for Biofrontera (BFRI) over the last 3 years, with Dec 2024 value amounting to $7,000.

  • Biofrontera's Short-term Investments rose 25.00% to $10,000 in Q3 2025 from the same period last year, while for Sep 2025 it was $10,000, marking a year-over-year increase of 25.00%. This contributed to the annual value of $7,000 for FY2024, which is 91.03% down from last year.
  • Per Biofrontera's latest filing, its Short-term Investments stood at $7,000 for FY2024, which was down 91.03% from $78,000 recorded in FY2023.
  • In the past 5 years, Biofrontera's Short-term Investments registered a high of $10.5 million during FY2022, and its lowest value of $7,000 during FY2024.
  • Moreover, its 3-year median value for Short-term Investments was $78,000 (2023), whereas its average is $3.5 million.
  • Data for Biofrontera's Short-term Investments shows a maximum YoY slumped of 99.26% (in 2023) over the last 5 years.
  • Yearly analysis of 3 years shows Biofrontera's Short-term Investments stood at $10.5 million in 2022, then tumbled by 99.26% to $78,000 in 2023, then crashed by 91.03% to $7,000 in 2024.